Table 2.

Results of Immunofluorescent Staining for FBG Incorporated Into A549 ECM in the Presence of Inhibitors

MoAbIL-6 + DEXIL-6 + DEX and Hirudin + Aprotinin
FPA (RVD3) + + 
FPB (18C6) + + 
β15-21 (T2G1) + + 
γ63-78 (J88B) + + 
MoAbIL-6 + DEXIL-6 + DEX and Hirudin + Aprotinin
FPA (RVD3) + + 
FPB (18C6) + + 
β15-21 (T2G1) + + 
γ63-78 (J88B) + + 

Hirudin and aprotinin inhibit thrombin and plasmin cleavage of FBG, respectively.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal